GlaxoSmithKline Pharmaceuticals Limited's total assets for Q4 2025 were ₹41.08B, an increase of Infinity% from the previous quarter. IN:GLAXO total liabilities were ₹21.57B for the fiscal quarter, a -228.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Total Assets
₹ 41.08B
₹ 35.57B
₹ 33.27B
₹ 46.33B
₹ 31.13B
Total Liabilities
₹ 21.57B
₹ 17.79B
₹ 15.85B
₹ 19.70B
₹ 16.14B
Total Equity Gross Minority
₹ 19.51B
₹ 17.78B
₹ 17.41B
₹ 26.63B
₹ 14.99B
Other Metrics
Currency in INR
GlaxoSmithKline Pharmaceuticals Limited Debt to Assets